FindTrial
Sign In

Feeding strategy during mucositis

Feeding strategy in pediatric cancer patients with gastro-intestinal mucositis: a multicenter prospective observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29080
Enrollment
15
Registered
2015-02-17
Start date
2015-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

University Medical Center Groningen(UMCG), Beatrix Children's Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children (0-18 yrs of age) admitted to the University Medical Center Groningen (UMCG) or Academic Medical Center (AMC) Amsterdam, for treatment of B Non Hodgkin lymphoma (B-NHL), or autologous stem cell transplantation(SCT)

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
Feeding strategy (tube feeding, tpn) and duration in days—

Secondary

MeasureTime frame
- Severity of mucositis measured by plasma citrulline (during regular vena punctures, no extra punctures will be done for study purpose only, the remaining plasma will be used to measure citrulline) - Number of days of mucositis >grade 1, and the peak severity of mucositis according to the NCI-CTCAE criteria - Weight, daily - Number of days with pain and the peak level of pain, daily measured with the VAS/Faces score - Days of analgesics, and the total amount of analgesics - The number of infectious complications and number of positive blood cultures - Length of hospital stay—

Contacts

Public ContactW.J.E. Tissing

Pediatric Oncologist and Hematologist Hanzeplein 1

w.j.e.tissing@umcg.nl+31 (0)50 3614213

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)